The invention relates to medicine, in particular to mono-and divalent sal ts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic anti depressant, anxyolytic, heroprotective, neuroprotective, antihypoxia cerebro protective and nootropic action. The novel compounds differ from the known p reparations, including the closest prior art in the form of a N-(5-hydroxyni cotinoil)-L-glutaminic acid base (nooglucotyl), in that they produce psychot ropic effects, namely antidepressant, anxyolytic, neuroprotective and heropr otective actions, in such a way that lesion focuses caused by apoplectic att acks are reduced and age-specific neurological deficiencies and intellectual and physical work capacities are improved.
MONO-AND DIVALENT SALTS OF N-(5-HYDROXYNICOTINOIL)-L-GLUTAMINIC ACID EXHIBITING PSYCHOTROPIC (ANTIDEPRESSANT AND ANXIOLYTIC), NEUROPROTECTIVE, HEROPROTECTIVE AND CEREBROPROTECTIVEACTION